glp-1 news today november 5 2025 Drugs: Pulse Survey (U.S.) glp-1 news today november 5

Pharmacogn J (2019) 11:7905

Clinical Evidence for GLP-1s in Hypertension Management Across randomized clinical trials and meta-analyses, GLP-1 receptor agonists have demonstrated average systolic blood pressure reductions ranging from approximately 2 to 6 mmHg

Special attention should also be paid to the usage cycle and storage

Cardiac Health: It supports heart health by maintaining normal heart rhythms and blood pressure levels

Acute gallbladder disease In trials for Mounjaro, 0.6% of participants reported gallbladder disease including gallstones, gallbladder inflammation, biliary colic (intermittent or constant abdominal pain), and cholecystectomy (surgical removal of the gallbladder)compared to 0% in the placebo group

10.1074/jbc.m109.032888 J